{ "items": [ "\n\n
\n \n 5 August 2022\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA large population-level assessment reveals third dose COVID-19 vaccination is effective for most patients with cancer, but effectiveness is lower than in the general population, particularly in patients who have undergone recent chemotherapy and those with lymphoma.
\n \n\n\n \n 29 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nBody mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.
\n \n\n\n \n 24 May 2022\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nCOVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
\n \n\n\n \n 18 May 2022\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Translational Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe collaboration will look at understanding the long-term effects of COVID-19 through cutting-edge MRI analysis.
\n \n\n\n \n 29 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Translational Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers have identified abnormalities in the lungs of long COVID patients who are experiencing breathlessness that cannot be detected with routine tests.
\n \n\n\n \n 25 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n Funding\n \n \n \n \n Research\n \n \n \n \n Teaching\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 5 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.
\n \n\n\n \n 16 December 2021\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nEileen is awarded funding for her research into the tumour microenvironment
\n \n\n\n \n 26 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Policy\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nAnneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.
\n \n\n\n \n 24 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford researchers will lead a \u00a32m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.
\n \n\n\n \n 19 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Translational Research\n \n \n\n \n\n\n
\n \n\n \n \n \nRob Stepney participated in a radiotherapy clinical trial in Oxford in 2021. He talks about his experience on the trial and accessing a state-of-the-art machine that uses real-time imaging to improve tumour targeting.
\n \n\n\n \n 13 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Translational Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe nursing team at the Early Phase Clinical Trials Unit has been awarded the Excellence in Cancer Research Nursing Award 2021.
\n \n\n\n \n 7 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana has found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.
\n \n\n\n \n 15 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n Translational Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.
\n \n\n\n \n 16 August 2021\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 1 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford is pleased to announce commencement of enrollment for the Phase I PanDox study of thermosensitive liposomal doxorubicin triggered by focused ultrasound in patients with pancreatic cancer.
\n \n\n\n \n 24 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.
\n \n\n\n \n 8 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nInitial success leads to new award for Oxford researcher pushing forward new cancer-hunting radiotherapy despite lockdown.
\n \n\n\n \n 25 March 2021\n \n
\n\n \n \n \n\n \n \n \nA new ViewRay MRIdian machine is the first of its kind in the UK and will be used by the University of Oxford, OUH and GenesisCare to help improve challenging cancer treatment through faster, tailored radiotherapy.
\n \n\n\n \n 17 February 2021\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResults from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
\n \n\n